Top ▲
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 361 | 2p22.2 | QPCT | glutaminyl-peptide cyclotransferase | |
Mouse | - | 362 | 17 E3 | Qpct | glutaminyl-peptide cyclotransferase (glutaminyl cyclase) | |
Rat | - | 313 | 6q11 | Qpct | glutaminyl-peptide cyclotransferase |
Previous and Unofficial Names |
GCT | glutaminyl cyclase | glutaminyl-tRNA cyclotransferase | QC | secretory glutaminyl cyclase (sQC) |
Database Links | |
Specialist databases | |
MEROPS | M28.974 (Hs) |
Other databases | |
Alphafold | Q16769 (Hs), Q9CYK2 (Mm) |
BRENDA | 2.3.2.5 |
ChEMBL Target | CHEMBL4508 (Hs), CHEMBL4105900 (Mm) |
Ensembl Gene | ENSG00000115828 (Hs), ENSMUSG00000024084 (Mm), ENSRNOG00000005705 (Rn) |
Entrez Gene | 25797 (Hs), 70536 (Mm), 313837 (Rn) |
Human Protein Atlas | ENSG00000115828 (Hs) |
KEGG Enzyme | 2.3.2.5 |
KEGG Gene | hsa:25797 (Hs), mmu:70536 (Mm), rno:313837 (Rn) |
OMIM | 607065 (Hs) |
Pharos | Q16769 (Hs) |
RefSeq Nucleotide | NM_012413 (Hs), NM_027455 (Mm), NM_001134557 (Rn) |
RefSeq Protein | NP_036545 (Hs), NP_081731 (Mm), NP_001128029 (Rn) |
SynPHARM | 82033 (in complex with PBD150) |
UniProtKB | Q16769 (Hs), Q9CYK2 (Mm) |
Wikipedia | QPCT (Hs) |
Selected 3D Structures | |||||||||||||
|
|||||||||||||
|
Enzyme Reaction | ||||
|
Substrates and Reaction Kinetics | ||||||||||||||||||||||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
View species-specific inhibitor tables |
Immuno Process Associations | ||
|
||
|
1. Buchholz M, Heiser U, Schilling S, Niestroj AJ, Zunkel K, Demuth HU. (2006) The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship. J Med Chem, 49 (2): 664-77. [PMID:16420052]
2. Hielscher-Michael S, Griehl C, Buchholz M, Demuth HU, Arnold N, Wessjohann LA. (2016) Natural Products from Microalgae with Potential against Alzheimer's Disease: Sulfolipids Are Potent Glutaminyl Cyclase Inhibitors. Mar Drugs, 14 (11). [PMID:27827845]
3. Hoang VH, Ngo VTH, Cui M, Manh NV, Tran PT, Ann J, Ha HJ, Kim H, Choi K, Kim YH et al.. (2019) Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design. J Med Chem, 62 (17): 8011-8027. [PMID:31411468]
4. Hoffmann T, Meyer A, Heiser U, Kurat S, Böhme L, Kleinschmidt M, Bühring KU, Hutter-Paier B, Farcher M, Demuth HU et al.. (2017) Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease-Studies on Relation to Effective Target Occupancy. J Pharmacol Exp Ther, 362 (1): 119-130. [PMID:28446518]
5. Mou J, Ning XL, Wang XY, Hou SY, Meng FB, Zhou C, Wu JW, Li C, Jia T, Wu X et al.. (2024) X-ray Structure-Guided Discovery of a Potent Benzimidazole Glutaminyl Cyclase Inhibitor That Shows Activity in a Parkinson's Disease Mouse Model. J Med Chem, 67 (11): 8730-8756. [PMID:38817193]
6. Pozzi C, Di Pisa F, Benvenuti M, Mangani S. (2018) The structure of the human glutaminyl cyclase-SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders. J Biol Inorg Chem, 23 (8): 1219-1226. [PMID:30132075]
7. Xu C, Wang YN, Wu H. (2021) Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors. J Med Chem, 64 (10): 6549-6565. [PMID:34000808]
8. Yu L, Zhao P, Sun Y, Zheng Z, Du W, Zhang L, Li Y, Xie L, Xu S, Wang P. (2023) Development of a potent benzonitrile-based inhibitor of glutaminyl-peptide cyclotransferase-like protein (QPCTL) with antitumor efficacy. Signal Transduct Target Ther, 8 (1): 454. [PMID:38097557]
M28: Aminopeptidase Y: glutaminyl-peptide cyclotransferase. Last modified on 05/06/2024. Accessed on 16/01/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2411.